RankAlpha logo
Back to Rankings

NUVB

Nuvation BioC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-08-04
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
NUVB vs peer average
54/100
NUVB vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 2 · D 1 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BHVN is the first available peer comparator.

Biohaven is a closer small/mid-cap biotech commercialization-and-pipeline comparison on risk appetite and catalyst trading, though its asset mix is not directly comparable to ROS1 lung cancer or IDH1 glioma.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBHVNBiohaven
NUVB
Nuvation Bio
BHVN
Biohaven
Grade
C
A
Momentum
89
78
Value
41
41
Sentiment
58
79
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs BHVN

NUVB / BHVN
Grade Position
In line
NUVB vs. peer average (C vs. C)
54/100
Momentum
89
NUVB
Value
41
NUVB
Sentiment
58
BHVN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NUVB
1
BHVN
BHVN
B
80/100
-1
2
NRIX
NRIX
F
20/100
+2
3
IOVA
IOVA
C
60/100
Even
4
VRDN
Viridian Therapeutics Inc Common
A
100/100
-2
5
SLS
SELLAS Life Sciences Group Inc Common
F
20/100
+2
BHVN is the first peer returned for this comparison set.